Clinical Trials
4
Active:0
Completed:1
Trial Phases
2 Phases
Phase 1:1
Phase 2:3
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (4 trials with phase data)• Click on a phase to view related trials
Phase 2
3 (75.0%)Phase 1
1 (25.0%)Reduced Dexamethasone Pre-Medication Dose in Elderly Patients Receiving Weekly Docetaxel
Phase 2
Terminated
- Conditions
- Breast CancerLung Cancer
- First Posted Date
- 2005-09-22
- Last Posted Date
- 2007-11-16
- Lead Sponsor
- Geriatric Oncology Consortium
- Target Recruit Count
- 40
- Registration Number
- NCT00215748
Bi-Weekly Administration of Docetaxel for Older Men With Hormone Refractory Prostate Cancer
Phase 1
Completed
- Conditions
- Prostate Cancer
- First Posted Date
- 2005-09-22
- Last Posted Date
- 2007-11-19
- Lead Sponsor
- Geriatric Oncology Consortium
- Target Recruit Count
- 17
- Registration Number
- NCT00215709
Study of Oxaliplatin, Capecitabine, and Bevacizumab to Treat Older Patients With Colorectal Cancer
Phase 2
Terminated
- Conditions
- Colorectal CancerNeoplasm Metastasis
- First Posted Date
- 2005-07-15
- Last Posted Date
- 2007-11-16
- Lead Sponsor
- Geriatric Oncology Consortium
- Target Recruit Count
- 40
- Registration Number
- NCT00120172
Pegylated Liposomal Doxorubicin Containing Chemotherapy in the Treatment of Older Non-Hodgkin's Lymphoma Patients
Phase 2
Terminated
- Conditions
- Non-Hodgkin's Lymphoma
- First Posted Date
- 2005-07-15
- Last Posted Date
- 2007-11-16
- Lead Sponsor
- Geriatric Oncology Consortium
- Target Recruit Count
- 50
- Registration Number
- NCT00120198
News
No news found